Role of JAK3 in CD40-mediated signaling

Blood

Volumn 92, Issue 7, 1998, Pages 2435-2440

  Jabara, Haifa H ^a   Buckley, Rebecca H ^b   Roberts, Joseph L ^b   Lefranc, Gerard ^b   Loiselet, Jacques ^b   Khalil, Georges ^b   Geha, Raif S ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 4; PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; ENZYME DEFICIENCY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0032188806     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2435     Document Type: Article

References (44)

1. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 12:881, 1994
2. Barrett TB, Shu G, Clark EA: CD40 signaling activates CD11a/ CD18 (LFA-l)-mediated adhesion in B cells. J Immunol 146:1722, 1991
3. Worm M, Geha RS: CD40 ligation induces lymphotoxin a gene expression in human B cells. Int Immunol 6:1883, 1994
4. Jabara HH, Fu SM, Geha RS, Vercelli D: CD40 and IgE: Synergism between anti-CD40 mAb and IL-4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 172:1861, 1990
5. Fuleihan R, Ramesh N, Geha, RS: X-linked agammaglobulinemia and Immunoglobulin deficiency with normal or elevated IgM: Immunodeficiencies of B cell development and differentiation. Adv Immunol 60:37, 1995
6. Xu J, Foy TM, Laman JD, Dunn JJ, Waldschmidt TJ, Elsemore J, Noelle RJ, Flavell RA: Mice deficient for the CD40 ligand. Immunity 1:423, 1994
7. Castigli E, Alt F, Davidson L, Bottaro A, Mizoguchi E, Bhan AK, Geha RS: CD40 deficient mice generated by RAG-2 deficient blastocyst complementation. Proc Natl Acad Sci USA 91:12135, 1994
8. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H: The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1:167, 1994
9. Cheng G, Cleary AM, Ye Z, Hong DI, Lederman S, Baltimore D: Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494, 1995
10. Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, Yamamoto T, Inoue T: Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an aminoterminal domain of the CD40 cytoplasmic region. J Biol Chem 271:28745, 1996
11. Mosialos G, Birkenbach M, Yalamanchilli R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP-1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
12. Nakano H, Oshima H, Chung W, Williams-Abbott L, Ware CF, Yagita H, Okumura K: TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J Biol Chem 271: 14661, 1996
13. Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424, 1995
14. Ren CL, Morio T, Fu SM, Geha RS: Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J Exp Med 179:673, 1994
15. Worm M, Geha RS: CD40-mediated lymphotoxin α expression in human B cells is tyrosine kinase dependent. Eur J Immunol 25:2438, 1995
16. Loh R, Ren C, Fu SM, Jabara H, Geha RS: Role of protein tyrosine kinases and phosphatases in isotype switching: Crosslinking CD45 to CD40 inhibits IgE isotype switching in human B cells. Immunol Lett 45:99, 1995
17. Hanissian S, Geha RS: JAK3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379, 1997
18. Xu Y, Cheng G, Baltimore D: Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5:407, 1996
19. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ: Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking JAK3. Science 270:794, 1995
20. Nosaka T, van Deursen JMA, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN: Defective lymphoid development in mice lacking JAK3. Science 270:800, 1995
21. Park SY, Saijo K, Takahashi T, Osawa M, Arase H, Hirayama N, Miyake K, Nakauchi H, Shirasawa T, Saito T: Developmental defects of lymphoid cells in JAK3 kinase-deficient mice. Immunity 3:771, 1995
22. Buckley RH, Schiff RI, Schiff S, Marken L, Williams L, Harville TO, Roberts J, Puck JM: Human severe combined immunodeficiency: Genetic, phenotyic and functional diversity in one hundred eight infants. J Pediatr 130:378, 1997
23. Macchi P, Villa A, Gilliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo LD: Mutations of JAK3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65, 1995
24. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone T-S, Noguchi M, Marken ML, Buckley RH, O'Shea JJ, Leonard WJ: Mutation of JAK3 in a patient with SCID: Essential role of JAK3 in lymphoid development. Science 270:797, 1995
25. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ: Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor. Science 262:1877, 1993
26. Umetsu DT, Leung DY, Siraganian R, Jabara HH, Geha RS: Differential requirement of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreajctive T cell clone. J Exp Med 162:202, 1985
27. Shapira S, Vercelli D, Jabara H, Fu SM, Geha R: Molecular analysis of the induction of IgE synthesis in human B cells by IL-4 and engagement of CD40 antigen. J Exp Med 175:289, 1992
28. Cooper MD, Butler JL: Primary immunodeficiency diseases, in Paul W (ed): Fundamental Immunology. New York, NY, Raven, 1989, p 1034
29. Conley M: X-linked severe combined immunodeficiency. Clin Immunol Immunopathol 61:S94, 1991 (suppl)
30. Defrance T, Carayon P, Billian G, Guillemot JC, Minty A, Caput D, Ferrara P: Interleukin 13 is a B cell stimulating factor. J Exp Med 179:135, 1994
31. Zurawski SM, Chomarat P, Djossous O, Bidaud C, McKenzie ANJ, Miossec P, Banchereau J, Zurawski G: The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270:13869, 1995
32. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995
33. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN: Involvement of the JAK-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153, 1994
34. Rolling C, Treton D, Beckmann P, Galanaud P, Richard Y: JAK3 associates with the human Interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering. Oncogene 10:1757, 1995
35. Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicola NA, Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93:497, 1996
36. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S: Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 157:3220, 1996
37. c chain. J Clin Invest 98:604, 1996
38. Izuhara K, Heike T, Otsuka T, Yamaoka K, Mayumi M, Imamura T, Niho Y, Harada N: Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem 271:619, 1996
39. Vercelli D, Geha RS: Regulation of isotype switching. Curr Opin Immunol 4:794, 1992
40. Collins T, Read MA, Neish AS, Whitely MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 9:899, 1995
41. Worm MM, Tsytsykova A, Geha RS: CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin α promoter in B cells. Eur J Immunol 28:901, 1998
42. Lai SY, Molden J, Liu KD, Puck J, White M, Goldsmith MA: Interleukin-4 specific signal transduction events are driven by homo-typic interactions of the interleukin-4 receptor α subunit. EMBO J 15:4506, 1996
43. Kammer W, Lischke A, Moriggl R, Groner B, Ziemiecki A, Gurniak CB, Berg LJ, Friedrich K: Homodimerization of interleukin-4 receptor a chain can induce intracellular signaling. J Biol Chem 271:23634, 1996
44. Kaplan D, Smith D, Huang R, Yildirim Z: Self-association of interleukin 2 bound to its receptor. FASEB J 9:1096, 1995